(Q33152525)

English

Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

hypertrophic obstructive cardiomyopathy

0 references

author name string

Thorsten Lawrenz

1

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Ludger Obergassel

2

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Frank Lieder

3

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Christian Leuner

4

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Claudia Strunk-Mueller

5

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Dorothee Meyer Zu Vilsendorf

6

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Gerald Beer

7

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Horst Kuhn

8

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Pacing and Clinical Electrophysiology

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

295-300

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Transcoronary ablation of septal hypertrophy (TASH): a 5-year experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

New treatment methods for patients with hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.09327.X

21 January 2018

Identifiers

10.1111/J.1540-8159.2005.09327.X

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

release_czpeovku6felnmuwtvkqiblaqa

1 reference

https://api.fatcat.wiki/v0/release/czpeovku6felnmuwtvkqiblaqa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33152525&oldid=1961333162"